| Literature DB >> 23826935 |
Ellen J T Nelissen1, Estomih Mduma, Hege L Ersdal, Bjørg Evjen-Olsen, Jos J M van Roosmalen, Jelle Stekelenburg.
Abstract
BACKGROUND: Maternal morbidity and mortality in sub-Saharan Africa remains high despite global efforts to reduce it. In order to lower maternal morbidity and mortality in the immediate term, reduction of delay in the provision of quality obstetric care is of prime importance. The aim of this study is to assess the occurrence of severe maternal morbidity and mortality in a rural referral hospital in Tanzania as proposed by the WHO near miss approach and to assess implementation levels of key evidence-based interventions in women experiencing severe maternal morbidity and mortality.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23826935 PMCID: PMC3716905 DOI: 10.1186/1471-2393-13-141
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
WHO near miss criteria adapted to the local context of HLH (reproduced from Nelissen et al.)
| Acute cyanosis | Acute cyanosis |
| Gasping | Gasping |
| Respiratory rate > 40 or < 6/min | Respiratory rate > 40 or < 6/min |
| Shock | Shock a |
| Oliguria non responsive to fluids or diuretics | Oliguria non responsive to fluids or diuretics b |
| Failure to form clots | Failure to form clots c |
| Loss of consciousness lasting > 12 h | Loss of consciousness lasting > 12 h d |
| Cardiac arrest | Cardiac arrest e |
| Stroke | Stroke f |
| Uncontrollable fit/total paralysis | Uncontrollable fit/total paralysis g |
| Jaundice in the presence of pre-eclampsia | Jaundice in the presence of pre-eclampsia h |
| Oxygen saturation < 90% for ≥ 60 minutes | Oxygen saturation < 90% for ≥ 60 minutes |
| PaO2/FiO2 < 200 mmHg | |
| Creatinine ≥ 300 μmol/l or ≥ 3.5 mg/dL | |
| Bilirubin > 100 μmol/l or > 6.0 mg/dL | |
| pH < 7.1 | |
| Lactate > 5 mEq/mL | |
| Acute thrombocytopenia (< 50,000 platelets/ml) | Acute thrombocytopenia (< 50,000 platelets/ml) |
| Loss of consciousness and ketoacids in urine | |
| | Admission to intensive care unit |
| Use of continuous vasoactive drugs | |
| Hysterectomy following infection or haemorrhage | Hysterectomy following infection or haemorrhage |
| Transfusion of ≥ 5 units of blood | Transfusion of ≥ 1 unit of blood |
| Intubation and ventilation for ≥ 60 minutes not related to anaesthesia | Intubation and ventilation for ≥ 60 minutes not related to anaesthesia |
| Dialysis for acute renal failure | |
| Cardio-pulmonary resuscitation | Cardio-pulmonary resuscitation |
| | Eclampsia i |
| | Sepsis or severe systemic infection j |
| Uterine rupture k | |
Applicability of the WHO near miss criteria in a low resource setting. PLoS One 2013, 8:e61248.
a: Shock is defined as a persistent severe hypotension, defined as a systolic blood pressure < 90 mmHg for 60 min with a pulse rate of ≥ 120/min despite aggressive fluid replacement (> 2 L).
b: Oliguria is defined as an urinary output < 30 ml/hour for 4 hours or < 400 ml/24 hr.
c: Failure to form clots is defined as the absence of clotting from the IV site after 7–10 minutes.
d: Unconsciousness/coma lasting > 12 hours is defined as a profound alteration of mental state that involves complete or near-complete lack of responsiveness to external stimuli or Glasgow Coma Scale < 10.
e: Cardiac arrest is defined as loss of consciousness and absence of pulse or heart beat.
f: Stroke is defined as a neurological deficit of cerebrovascular cause that persists ≥ 24 hours, or is interrupted by death within 24 hours.
g: Uncontrollable fit is a condition in which the brain is in state of continuous seizure.
h: Pre-eclampsia: the presence of hypertension associated with proteinuria. Hypertension is defined as a blood pressure ≥ 140 mmHg (systolic) or ≥ 90 mmHg (diastolic). Proteinuria is defined as excretion of ≥ 300 mg protein/24 hr or 300 mg protein/litre urine or ≥ 1+ on a dipstick.
i: Eclampsia is defined as the presence of hypertension associated with proteinuria and fits. Hypertension is defined as a blood pressure ≥ 140 mmHg (systolic) or ≥ 90 mmHg (diastolic). Proteinuria is defined as excretion of ≥ 300 mg protein/24 hr or 300 mg protein/litre urine or ≥ 1+ on a dipstick.
j: Sepsis is defined as a clinical sign of infection and 3 of the following: temp > 38°C or < 36°C, respiration rate > 20/min, pulse rate > 90/min, WBC >12.
k: Uterine rupture is defined as the complete rupture of a uterus (including peritoneum) with (partial) extrusion of the fetus during labour.
Demographic and clinical characteristics
| Age mean (SD) in years | 28.1 (6.3) | 29.4 (6.1) | p = 0.266* |
| < 20 years n (%) | 20 (9%) | 3 (9%) | |
| 20-35 years n (%) | 150 (69%) | 20 (63%) | |
| ≥ 35 years n (%) | 46 (21%) | 9 (28%) | |
| Marital status n (%) | | | p = 0.341*** |
| Single/separated/divorced | 21 (10%) | 5 (16%) | |
| Married/cohabiting | 188 (87%) | 25 (78%) | |
| Unknown | 7 (3%) | 2 (6%) | |
| Tribe n (%) | | | p = 0.477** |
| Datoga | 31 (14%) | 7 (22%) | |
| Iraqw | 114 (53%) | 14 (44%) | |
| Other | 61 (28%) | 9 (28%) | |
| Unknown | 10 (5%) | 2 (6%) | |
| Parity n (%) | | | p = 0.742** |
| 0 | 47 (22%) | 5 (16%) | |
| 1-2 | 52 (24%) | 7 (22%) | |
| ≥ 3 | 100 (46%) | 16 (50%) | |
| Unknown | 17 (8%) | 4 (13%) | |
| Previous caesarean section n (%) | | | p = 0.307*** |
| No | 145 (67%) | 24 (75%) | |
| Yes | 41 (19%) | 3 (9%) | |
| Unknown | 30 (14%) | 5 (16%) | |
| Gestational age n (%) | | | p = 0.106** |
| < 24 weeks | 40 (19%) | 7 (22%) | |
| 24-36 weeks | 40 (19%) | 10 (31%) | |
| ≥ 36 weeks | 91 (42%) | 8 (25%) | |
| Unknown | 45 (21%) | 7 (22%) | |
| Mode of delivery n (%) | | | **** |
| Vaginal delivery | 80 (37%) | 15 (47%) | |
| Caesarean section | 69 (32%) | 5 (16%) | |
| Laparotomy for uterine rupture | 16 (7%) | 1 (3%) | |
| Abortion/curettage | 22 (10%) | 2 (6%) | |
| Laparotomy for ectopic pregnancy | 19 (9%) | - | |
| Undelivered | 9 (4%) | 9 (28%) | |
| Unknown | 1 (1%) | - | |
| Fetal presentation n (%) | | | **** |
| Cephalic | 110 (51%) | 15 (47%) | |
| Breech | 10 (5%) | 1 (3%) | |
| Other | 9 (4%) | 1 (3%) | |
| Abortion | 40 (19%) | 4 (13%) | |
| Unknown | 47 (22%) | 11 (34%) |
* Independent sample t-test; ** Chi-square test; *** Fisher exact test (2-sided); **** p-value could not be calculated due to too few cases.
Outcome indicators
| All live births in the hospital (n) | 9136 |
| | |
| Maternal deaths (n) | 32 |
| Maternal near miss cases (n) | 216 |
| Women with life-threatening conditions (WLTC) (n) | 248 |
| | |
| Severe maternal outcome ratio (SMOR) (per 1,000 live births) | 27.1 |
| Maternal near miss incidence ratio (per 1,000 live births) | 23.6 |
| Maternal near miss mortality ratio | 6.75 |
| Case fatality rate (%) | 12.9% |
| | |
| WLTC at hospital arrival (n) | 172 |
| Proportion WLTC at arrival among all WLTC (%) | 69.4% |
| Proportion of WLTC at arrival coming from other hospitals (%) | 20.9% |
| WLTC at arrival mortality index (%) | 7.6% |
| | |
| Intra hospital WLTC cases (n) | 76 |
| Intra hospital WLTC rate (per 1,000 live births) | 8.32 |
| Intra hospital mortality index (%) | 5.3% |
Live birth (LB): the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of the pregnancy, which, after such separation, breathes or shows any other evidence of life. Each product of such a birth is considered live born.
Women with life-threatening conditions (WLTC): the sum of maternal near miss and maternal deaths. (WLTC = MNM + MD).
Severe Maternal Outcome Ratio (SMOR): the number of women with life‒threatening conditions per 1,000 live births. [SMOR = (MNM + MD)/LB].
MNM incidence ratio: the number of maternal near miss cases per 1,000 live births. [MNM IR = MNM/LB].
Maternal near miss : mortality ratio: the proportion between maternal near miss cases and maternal deaths. [MNM : 1 MD].
Case fatality Rate: the number of maternal deaths divided by the number of women with life-threatening conditions, expressed as a percentage. [CFR = MD/(MNM + MD)].
WLTC at hospital arrival: the number of women with life‒threatening conditions who are ill on arrival.
Proportion WLTC at arrival among all WLTC: the number of WLTC who are ill on arrival divided by the total number of WLTC.
Proportion of WLTC at arrival coming from other hospitals: the number of WLTC who are ill on arrival and coming from another hospital divided by the total number of WLTC at arrival.
WLTC at arrival mortality index: the maternal deaths within 24 hours after arrival (MD24) divided by the number of women with life-threatening conditions who were ill on arrival, expressed as percentage. [WLTC at arrival MI = MD24/(WLTC at arrival)].
Intra hospital WLTC cases: the number of women with life-threatening conditions who developed these life-threatening conditions in the hospital.
Intra hospital WLTC rate (per 1000 live births): the number of women with life-threatening conditions who developed these life-threatening conditions in the hospital per 1000 live births.
Intra hospital mortality index: the number of maternal deaths who were not ill on arrival, divided by the number of women with life-threatening conditions who were not ill on arrival, expressed as percentage.
Underlying causes of maternal morbidity and mortality (mutually exclusive, totally inclusive)
| Indirect | Anaemia in pregnancy | 19 (8%) | 0% |
| | Infectious disease | 11 (4%) | 63% |
| | Cardiac disease | 4 (2%) | 50% |
| | Cerebral disease | 2 (1%) | 50% |
| Direct | Postpartum haemorrhage | 67 (27%) | 9% |
| | Abortion related complication | 43 (17%) | 7% |
| | Ante partum haemorrhage | 26 (11%) | 8% |
| | Hypertensive disorders | 21 (9%) | 10% |
| | Obstructed labour with uterine rupture | 15 (6%) | 13% |
| | Obstructed labour without uterine rupture | 15 (6%) | 7% |
| | Uterine scar rupture without obstructed labour | 6 (2%) | 0% |
| | Puerperal sepsis | 9 (4%) | 0% |
| | Anaesthesia related complication | 1 (0.4%) | 0% |
| Co-incidental | Cancer | 3 (1%) | 67% |
| | Trauma | 1 (0.4%) | 0% |
| Unknown | Unknown/undetermined cause | 5 (2%) | 80% |
* CFR: case fatality rate, calculated as MD/(MD + MNM).
Process indicators among women with severe maternal morbidity and mortality
| Target population: women who delivered in hospital | 201 (100%) |
| Oxytocin use for AMTSL | 96 (48%) |
| Other uterotonic use for AMTSL | 2 (1%) |
| All uterotonic use for AMTSL | 96 (48%) |
| Target population: women with PPH | 66 (100%) |
| Delivery in hospital | 41 (62%) |
| Delivery out hospital | 25 (38%) |
| Oxytocin use (routine) | 28 (42%) |
| Other uterotonic use (routine) | - |
| All uterotonic use (routine) | 28 (42%) |
| Oxytocin use (treatment) | 38 (58%) |
| Other uterotonic use (treatment) | 10 (15%) |
| All uterotonic use (treatment) | 39 (59%) |
| IV-infusion | 54 (82%) |
| Blood products | 61 (92%) |
| Hysterectomy | 4 (6%) |
| CFR | 9% |
| Target population: women with eclampsia | 15 (100%) |
| Magnesium sulphate use | 13 (87%) |
| Other anticonvulsant use | 10 (67%) |
| Any anticonvulsant use | 14 (93%) |
| CFR | 7% |
| Target population: women with caesarean section | 74 (100%) |
| Prophylactic antibiotics | 49 (66%) |
| Target population: women with sepsis | 30 (100%) |
| Parenteral therapeutic antibiotics | 28 (93%) |
| CFR | 27% |
| Target population: women with uterine rupture | 21 (100%) |
| Occurred in hospital | 13 (62%) |
| Occurred out hospital | 8 (38%) |
| Laparotomy | 21 (100%) |
| CFR | 5% |
PPH: postpartum haemorrhage, this is defined as the loss of 500 ml of blood or more; AMTSL: active management of third stage of labour; CFR: case fatality rate, calculated as MD/(MD + MNM).